logo

FERMENTA vs VIVIMEDLAB: Stock Comparison

FERMENTA BIOTECH vs VIVIMEDLABUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

FERMENTA BIOTECH is the larger company by market capitalisation. FERMENTA BIOTECH shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FERMENTA leads 10; VIVIMEDLAB leads 0 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FERMENTAVIVIMEDLAB

Valuation lens

What price are you paying?

Market CapContext only
₹1,354 Cr
₹53 Cr
P/E RatioSame reading
22.61x
—
P/B RatioSame reading
3.33x
—
EPSFERMENTA has the higher reading
₹3.31 ✓
₹-17.61
Book ValueContext only
₹136.1
—
Dividend YieldFERMENTA has the higher reading
0.81% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FERMENTA is the larger company
₹1,354 Cr vs ₹53 Cr
EPS
FERMENTA has higher earnings per share
₹3.31 vs ₹-17.61
Dividend Yield
FERMENTA has a higher dividend yield
0.81% vs 0%
Revenue Growth (TTM YoY)
FERMENTA has faster revenue growth
0% vs -22.42%
Qtr Sales Growth
FERMENTA has stronger quarterly sales growth
0% vs -24.95%
Qtr Profit Growth
FERMENTA has stronger quarterly profit growth
0% vs -782.17%
ROE
FERMENTA has a higher ROE
15.2% vs -57.01%
ROCE
FERMENTA has a higher ROCE
13.88% vs -5.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFERMENTAVIVIMEDLAB
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricFERMENTAVIVIMEDLAB
Live Price₹460.5₹7.39
Day Change-5.25%-3.15%
Volume84,4691.47 L
52-Week High₹582.65₹20.59
52-Week Low₹248.85₹5.15
Distance from 52W High-20.96%-64.11%

Valuation

MetricFERMENTAVIVIMEDLAB
Market Cap₹1,354 Cr₹53 Cr
P/E Ratio22.61x—
P/B Ratio3.33x—
EPS₹3.31₹-17.61
Book Value₹136.1—
Dividend Yield0.81%0%

Growth

MetricFERMENTAVIVIMEDLAB
Revenue Growth (TTM YoY)0%-22.42%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%-24.95%
Qtr Profit Growth0%-782.17%

Profitability & Leverage

MetricFERMENTAVIVIMEDLAB
ROE15.2%-57.01%
ROCE13.88%-5.3%
Net Margin13.37%-27.09%
Operating Margin22.37%-40.67%
Debt to Equity0.26x8.29x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFERMENTAVIVIMEDLAB
Promoter Holding56.47%7.57%▼ 0.2 pp
FII Holding0.13%▲ 0.11 pp1.64%
DII Holding0.04%▲ 0.04 pp0%
Public Holding33.2%▼ 0.1 pp90.67%▲ 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FERMENTA BIOTECH and VIVIMEDLAB.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.